Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies

• Yiting Wang,
• Yiting Wang,
• Hubing Shi,
• Huan Meng,
• Jie Xu

Affiliations

Yiting Wang

Institutes of Biomedical Sciences, Zhongshan-Xuhui Hospital, Key Laboratory of Epigenetics and Metabolism, Fudan University, Shanghai, China

Yiting Wang

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Hubing Shi

The State Key Laboratory of Biotherapy, Sichuan University West China Hospital, Chengdu, China

Huan Meng

Division of Nanomedicine, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States

Jie Xu

Institutes of Biomedical Sciences, Zhongshan-Xuhui Hospital, Key Laboratory of Epigenetics and Metabolism, Fudan University, Shanghai, China